Interview: Dr. William Yasnoff on patient-centric IT ( For this special issue of Wisconsin Te...)

(Date:11/23/2009)...n a provocative new study, a University of Utah sc...s the major cause of global warming cannot be st...ociety builds the equivalent of one new nuclear po...here will be any substantial near-term departure f...de emission rates," says the new paper by Tim Garr...

(Date:11/23/2009)...PRNewswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasd...vember27,2009astheex-dividenddateforits$200million...itizationtransactioncompletedonNovember2,2009.Thed...sofrecordontherecorddate,December1,2009.NASDAQhass...pershareofcommonstockforpurposesoftheex-dividendda...

(Date:11/23/2009)...-ImmuneDesignC or p.(IDC)announcedtodaythatDr.Bruc...erhasasuccessfultrackrec or dinbiotechnologyexecut...ratZymoGenetics,inSeattle,WAandChiefScientificOffi...o: http://www.newscom.com/cgi-bin/prnh/20091123/SF...ecutiveOfficercommented,"IamdelightedtowelcomeDr.B...

(Date:11/23/2009)...-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq: C...iring,developingandcommercializingsignificantprodu...ayannouncedthatCraigA.Collard,PresidentandChiefExe...the21stAnnualPiperJaffrayHealthCareConferenceat3:3...otelinNewYorkCity. ,, Aliveaudioandarchivedwebc...

Breaking Biology Technology:Is global warming unstoppable? 2 Is global warming unstoppable? 3 Is global warming unstoppable? 4 PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2 Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2 Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2
[0] Is global warming unstoppable?[0] PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend [0] Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director [0] Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference

...Management Changes Announced, NEW YORK, March 5 ...nnounced that the company,s Board of Directors,has...chief financial,officer, effective March 31, 2008....recting and managing the company,s fiscal operatio...the organization and its,subsidiaries. Andrew Bonf...

...se II study of 20 patients reported in Annals of O....,(CTI) (Nasdaq: CTIC ; MTA) today announced the ...lts of a limited phase II study of CHOP chemothera...d prednisone) followed by,administration of Zevali...0,years of age or older) with previously untreated...

...lbaum, assistant professor of electrical and compu... received the prestigious Faculty Early Career Dev...n for his pioneering research in the exciting next... This emerging field focuses on harnessing the mag...ctronics ranging from computers to cell phones tha...

Other Biology Technology:Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 2 Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 3 CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 2 CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 3 CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 4 UD's Appelbaum wins NSF Career Award for research on silicon spintronics 2 UD's Appelbaum wins NSF Career Award for research on silicon spintronics 3
Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma UD's Appelbaum wins NSF Career Award for research on silicon spintronics

(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...

(Date:11/24/2009)...bby arteries from collapsing have been true life-s...onger needed -- once the arteries are strengthened... no choice but to leave them in place. , Prof. M...t of Biomedical Engineering has developed a new pa...re they,re needed, then dissolves. , "Our new co...

(Date:11/24/2009)... of Medical Toxicology (ACMT) have signed an agree...rnal of Medical Toxicology (JMT), the official jo...s previously published by the University of Pennsy...ogy , an international, peer-reviewed journal, is ... medical toxicology. The quarterly journal focuse...

Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2 A coating for life 2 Springer and the American College of Medical Toxicology to work together 2 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 1 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 2 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 3 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 4 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 5 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 6 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 7 Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 8 Carondelet St Marys Medical Plaza II Opens In Tucson 55314 1 MicroRNA in human saliva may help diagnose oral cancer 9696 1
[0] Rocket science leads to new whale discovery [0] A coating for life [0] Springer and the American College of Medical Toxicology to work together

...ced a major expansion of a lingua franca used to d...s. The expansion provides terms that scientists c...hen a pathogenic or beneficial microbe encounters ...r developing new interventions for preventing infe...g or encouraging the presence of beneficial microb...

...s of other individuals in order to cooperate in co...we humans take for granted. But, according to evol... Institute in Germany, this ability is present in ...April issue of Current Directions in Psychological... gaze and face orientation to monitor others, beha...

...may explain why Graves?disease (GD) attacks the mu... bulge painfully from their sockets, as in the lat...s Stein Eye Institute and Harbor-UCLA Medical Cent...cells of GD patients?immune systems. Reported Mar... deepen understanding of how the autoimmune disord...

Other Biology News:Uniform language for describing genes of pathogenic and beneficial microbes 2 Uniform language for describing genes of pathogenic and beneficial microbes 3 Man's best friend lends insight into human evolution 2 UCLA study uncovers clues for why Graves' disease attacks the eyes 2
Uniform language for describing genes of pathogenic and beneficial microbes Man's best friend lends insight into human evolution UCLA study uncovers clues for why Graves' disease attacks the eyes

Viraffinity 100 from Biotech Support Group

Tumor Suppressor Sampler Kit from BD Biosciences Pharmingen

Mouse Anti-Synapsin I Monoclonal Antibody, Unconjugated, Clone 223 from IMGENEX

Slide Chambers from Novagen

Biology Products:
Viraffinity 100 from Biotech Support Group Tumor Suppressor Sampler Kit from BD Biosciences Pharmingen Mouse Anti-Synapsin I Monoclonal Antibody, Unconjugated, Clone 223 from IMGENEX Slide Chambers from Novagen

( For this special issue of Wisconsin Te...)Interview: Dr. William Yasnoff on patient-centric IT